Immatics
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.
Last updated on
About Immatics
Founded
2000Estimated Revenue
$10M-$50MEmployees
251-1KFunding / Mkt. Cap
$556MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
TuebingenState
Baden-WuerttembergCountry
GermanyTech Stack (88)
Programming Languages And Frameworks
Devops And Development
Platform And Storage
Business Intelligence And Analytics
Customer Management
Marketing
Productivity And Operations
IT Management
IT Security
Analytics and Tracking
Widgets
WPBakery
Yoast Plugins
Font Awesome
Google Font API
Sitelinks Search Box
Twemoji
Wordpress Plugins
Contact Form 7
ThemePunch
Slider Revolution
YouTube Advanced by Embed Plus
WP Logo Showcase
Advanced WordPress Backgrounds
Ionicons
CrUX Dataset
Matomo for Wordpress
Cloudflare Radar
EmbedPress
Real Testimonials for Wordpress
YouTube IFrame Upload